home / stock / lobed / lobed short
Short Information | Lobe Sciences Ltd (OTCMKTS:LOBED)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 118,236 |
Total Actual Volume | 185,015 |
Short Trends | |
---|---|
Cover Days | 8 |
Short Days | 4 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 5,912 |
Average Short Percentage | 24.46% |
Is there a LOBED Short Squeeze or Breakout about to happen?
See the LOBED Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-07-2022 | $0.05 | $0.0403 | $0.052 | $0.0403 | 10,576 | 184 | 1.74% |
07-05-2022 | $0.0501 | $0.0504 | $0.0504 | $0.0501 | 3,053 | 30 | 0.98% |
07-01-2022 | $0.041845 | $0.0625 | $0.0625 | $0.0418 | 5,294 | 2 | 0.04% |
06-29-2022 | $0.031 | $0.031 | $0.031 | $0.031 | 401 | 16 | 3.99% |
06-28-2022 | $0.03535 | $0.0536 | $0.0536 | $0.0343 | 2,266 | 516 | 22.77% |
06-27-2022 | $0.062 | $0.0494 | $0.062 | $0.0494 | 102,585 | 100,160 | 97.64% |
06-24-2022 | $0.035 | $0.05 | $0.0686 | $0.035 | 7,891 | 1,566 | 19.85% |
06-23-2022 | $0.0519 | $0.051 | $0.0519 | $0.035 | 20,429 | 1,992 | 9.75% |
06-21-2022 | $0.0281 | $0.0487 | $0.0487 | $0.0281 | 3,042 | 1,069 | 35.14% |
06-15-2022 | $0.0407 | $0.0514 | $0.0514 | $0.0407 | 16,502 | 200 | 1.21% |
06-14-2022 | $0.03 | $0.0298 | $0.05 | $0.0298 | 11,892 | 11,417 | 96.01% |
06-13-2022 | $0.03031 | $0.025 | $0.0303 | $0.025 | 750 | 750 | 100% |
06-10-2022 | $0.04702 | $0.047 | $0.047 | $0.047 | 334 | 334 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Lobe Sciences Ltd Company Name:
LOBED Stock Symbol:
OTCMKTS Market:
Move Affirms Lobe's Position as an Orphan/Rare Disease Drug Development Company and expands portfolio to include 4 Orphan Disease Programs The Company expects to Launch Altemia™, a Medical Food, and Generate Commercial Revenue in the Second Half of 2023 Acquisition also Includes an Inte...
Distribution Agreement Grants Pentec Exclusive Distribution Rights for Altemia Lobe’s Novel Sickle Cell Anemia Medical Food Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat...
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2023) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the " Company "), a North American Biopharmaceutical Company committed to discovering and developing patient-focused medicines for Orphan and Rare diseases today provides an u...